Abstract
Constant production of reactive oxygen species (ROS) during aerobic metabolism is balanced by antioxidant defense system of an organism. Although low level of ROS is important for various physiological functions, its accumulation has been implicated in the pathogenesis of age-related diseases such as cancer and coronary heart disease and neurodegenerative disorders such as Alzheimer’s disease. It is generally assumed that frequent consumption of phytochemicals derived from vegetables, fruits, tea and herbs may contribute to shift the balance towards an adequate antioxidant status. The present study is aimed to investigate the effect of aqueous extract of medicinal plant Terminalia arjuna on antioxidant defense system in lymphoma bearing AKR mice. Antioxidant action of T. arjuna is monitored by the activities of catalase, superoxide dismutase and glutathione S transferase which constitute major antioxidant defense system by scavenging ROS. These enzyme activities are low in lymphoma bearing mice indicating impaired antioxidant defense system. Oral administration of different doses of aqueous extract of T. arjuna causes significant elevation in the activities of catalase, superoxide dismutase and glutathione S transferase. T. arjuna is found to down regulate anaerobic metabolism by inhibiting the activity of lactate dehydrogenase in lymphoma bearing mice, which was elevated in untreated cancerous mice. The results indicate the antioxidant action of aqueous extract of T. arjuna, which may play a role in the anti carcinogenic activity by reducing the oxidative stress along with inhibition of anaerobic metabolism.
Similar content being viewed by others
References
Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620–1622
Dean RT, Fu S, Stocker R, Davies MJ (1997) Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 324:1–18
Pattanayak D, Chatterjee SR (1999) Inactivation of sunflower NADH:Nitrate reductase by White Light-Activated Rose Bengal. Mol Cell Biol Commun 138:237–240
Pasquini R, Scassellati-Sforzolini G, Villarini M, Moretti M, Marcarelli M, Fatigoni C, Kaur S, Kumar S, Grover IS (2002) In vitro protective effects of Terminalia arjuna bark extract against the 4-nitroquinoline-N-oxide genotoxicity. J Environ Pathol Toxicol Oncol 21:33–44
Jain V, Poonia A, Agarwal RP, Panwar RB, Kochar DK, Misra SN (1992) Effect of Terminalia arjuna in patients of angina pectoris. Indian Med Gaz 36:56–59
Hartwell JL (1982) Plants Used Against Cancer. Quarterman Publication, Lawrence, MA, pp 274–275
Nandkarni AK (1976) In: Nandkarni AK, Nandkarni KM (eds) Indian Materia Medica. Popular Prakashan Private Limited, Mumbai, vol 1. pp 1199–1202
Nesamony S (1998) Ovshadhya Sasyangai (Medicinal plants). State Institute for Language Kerala, India, pp 314–316
Tiwari AK, Gode JD, Dubey GP (1990) Effect of Terminalia arjuna on lipid profiles of rabbits fed hypercholesterolemic diet. Int J Crude Drug Res 28:43–47
Khanna AK, Chander R, Kapoor NJ (1996) Terminalia arjuna an ayurvedic cardiotonic regulates lipid metabolism in hyperlipaemic rats. Phytotherapy Res 10:663–665
Shaila HP, Udupa SL, Udupa AL, Nair NS (1997) Effect of Terminalia arjuna on experimental hyperlipidemia in rabbits. Int J Pharmacol 35:1–4
Gauthaman K, Maulik M, Kumari R, Manchandra SC, Dinda AK, Maulik SK (2001) Effect of chronic treatment with bark of Terminalia arjuna a study in isolated ischemicreperfused rat heart. J Ethnopharmacol 75:197–201
Dwivedi S, Gupta D (2002) Efficacy of Terminalia arjuna in chronic stable angina. Ind Heart J 54:170–175
Gupta R, Nair S (1997) Antioxidant flavonoides in Indian diet. In: Shyam Singh (ed) Current Advances in Atherosclerosis Research Part I. Central Drug Research Institute, 35–50
Kandil FE, Soliman AM (1998) A new tannin anticancer promotor from Terminalia arjuna. 2nd International Electronic Conference on Synthetic Organic Chemistry (ECSOC-2), Sept, pp 1–30
Verma N, Vinayak M (2007) Antioxidant action of Andographis paniculata on lymphoma. Mol Biol Reports (In Press)
Pathak C, Vinayak M (2005) Modulation of lactate dehydrogenase isozymes by modified base queuine. Mol Biol Reports 32:191–196
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 248–254
Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Method in enzymology, 2, Academic press, New York, pp 673–678
Woodbury W, Spencer AK, Stahman MA (1971) An improved procedure using ferricyanide for detecting catalase isozymes. Anal Biochem 44:301–305
Winterbourn CC, Hawkins RE, Brian M, Carrell RW (1975) The estimation of red cell superoxide dismutase activity. J Lab Clin Med 85:337–341
Beauchamp C, Fridovich I (1971) Superoxide dismutase: an improved assays and an assay applicable to acrylamide gel. Anal Biochem 44:276–287
Habig WH, Michael PJ, Jakoby WB (1974) Glutathione S transferase: the first enzymatic step in mercapturic acid formation. J Bio Chem 249:7130–7139
Sun Y (1990) Free radicals, antioxidant enzyme and carcinogenesis. Free Radic Biol Med 8:583–599
Corrocher R, Casaril M, Bellisola G, Gabreelli GB, Nicoli N, Guidi GC, De SG (1986) Severe impairment of antioxidant system in human hepatoma. Cancer 58:1658–1662
Kahlos K, Soini Y, Sormunen R, Wiik RK, Paakko P, Linnainmaa K, Kinnula VL (2001) Expression and prognostic significance of catalase in malignant mesothelioma. Cancer 91:1349–1357
Macmillan CLA, Cruthirds DL (2001) Manganese superoxide dismutase in disease. Free Radic Res 34:25–336
Marklund S (1982) Human copper containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci USA 76:7634–7638
Mitrunen K, Jourenkova N, Kataja V (2001) Glutathione S-transferases, M1, M3, P1 and T1 genetic polymorphism and susceptibility to breast cancer. Cancer Epidemiol Biomark Prev 10:229–236
Pathak C, Jaiswal YK, Vinayak M (2008) Modulation in the activity of lactate dehydrogenase and level of c-Myc and c-Fos by modified base queuine in cancer. Cancer Biol Ther 7:1–7
Kaul SC, Nagpal A, Laxman SM, Kaur S, Grover IS, Wadhwa R (2000) Growth suppression of human transformed cells by treatment with bark extracts from a medicinal plant, Terminalia arjuna. In Vitro Cell Dev Biol Anim 36:544–547
Acknowledgements
Nibha Verma thanks Indian Council of Medical Research, New Delhi, India for providing Senior Research Fellowship. The work is supported by the grants received from University Grants Commission, India under CAS programme.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Verma, N., Vinayak, M. Effect of Terminalia arjuna on antioxidant defense system in cancer. Mol Biol Rep 36, 159–164 (2009). https://doi.org/10.1007/s11033-008-9279-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-008-9279-3